PAVmed Inc. Series Z Warrant
PAVMZ
PAVMZ was delisted on the 30th of April, 2025.
7 hedge funds and large institutions have $1.42M invested in PAVmed Inc. Series Z Warrant in 2018 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
17% more funds holding
Funds holding: 6 → 7 (+1)
44% less capital invested
Capital invested by funds: $2.53M → $1.42M (-$1.11M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$663K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$62.1K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$2.92K |
| 4 |
LCS
Levin Capital Strategies
New York
|
+$2.04K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$1.46M |
PAVMZ Hedge Fund Activity: Q4 2018 in Review
7 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in PAVmed Inc. Series Z Warrant (PAVMZ) for Q4 2018, worth a combined $1.42M — down 44% from $2.53M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new PAVMZ positions and 1 closed out — a net gain of 1 holder — while 3 added to existing stakes and 0 trimmed.
The largest buyer was Sabby Management, adding an estimated $663K. The largest seller was Anson Funds Management, exiting entirely with an estimated $1.46M sold.
- 7 institutional investors held PAVmed Inc. Series Z Warrant (PAVMZ) as of Q4 2018, up from 6 in Q3 2018.
- Funds reported $1.42M of PAVmed Inc. Series Z Warrant stock for Q4 2018, down 44% quarter-over-quarter.
- 2 funds opened new PAVmed Inc. Series Z Warrant positions in Q4 2018 and 1 closed out, a net change of +1 holder.
- The largest PAVmed Inc. Series Z Warrant buyer in Q4 2018 was Sabby Management, an estimated $663K added.
- The largest PAVmed Inc. Series Z Warrant seller in Q4 2018 was Anson Funds Management, an estimated $1.46M sold.
Based on aggregated 13F filings for Q4 2018.